EDITION:

Home Business of Cannabis North America

Canadian Cannabis Awards | Terry Parker

byBofC

November 30, 2018

in Business of Cannabis North America, Medical, Newsfeed, Videos, Your #1 Podcast on Cannabis News

Share on Facebook Share on Twitter

📊 New Report Available Now

Relm Risk Briefing: Cannabis 2026

The global cannabis sector has moved from experiment to enterprise. This comprehensive risk briefing examines how regulation, insurance, and operational practices intersect across the international supply chain, drawing on insights from RELM—the only insurer entirely dedicated to the cannabis industry.

What's covered

🌱 Cultivation risk management — biological contamination, environmental instability, and security protocols
⚗️ Manufacturing & extraction — GMP standards, in-house testing, and quality control measures
🔬 Testing & compliance — rigorous protocols ensuring product safety and regulatory adherence
📦 Distribution & logistics — GDP-aligned transport, route monitoring, and cargo insurance

Key focus areas

Cultivation Manufacturing Testing & QC Packaging Distribution Retail & Pharmacy

100% free • Comprehensive risk analysis

Key insights

Industry Maturity Cannabis has evolved from patchwork markets to international enterprise, with risk management now the measure of long-term stability.

Cultivation Challenges Operators addressing biological contamination through controlled-environment agriculture, tissue culture, and IPM protocols.

Quality Control GMP adherence, in-house testing, and selective supplier relationships emerging as critical control points.

Supply Chain Security GDP-aligned transport, route monitoring, and comprehensive insurance remain essential safeguards.

Market Access Initiatives stabilizing domestic supply and expanding pharmacy training improving patient and consumer access.

Produced by Prohibition Partners in collaboration with RELM—the only insurer dedicated to emerging industries like cannabis.

Partnership

Produced by Prohibition Partners in collaboration with RELM

Tags: advocacy canadian cannabis awards lift lift & Co medical cannabis terry parker

Canadian Cannabis Awards | Larry Lisser, HelloMD

BofC

Editorial Picks

Spanish Pharmacists Appeal Hospital-Only Cannabis Rule as Key Regulatory Deadline Passes Unmet

by Ben Stevens

January 9, 2026

Spain represents one of the most exciting incoming additions to the European medical cannabis market this year, as one of...

Editorial Picks

Inside the Medical Cannabis Police Guidance: Cancards, Driving, and What Patients Need to Know

by Ben Stevens

January 8, 2026

Earlier this week, the first official guidance on medical cannabis for police officers in England and Wales was made public. Its...

UK Police Finally Get Official Medical Cannabis Guidance More Than 7 Years After Legalisation

January 7, 2026

Empty blue plenary seats in the German Bundestag debating chamber inside the Reichstag building.

Germany’s Medical Cannabis Bill Faces Critical Test as Experts Warn of ‘Unenforceable’ Framework

January 6, 2026

Cannabis Rescheduling: The industry weighs in

Industry Leaders React to Historic Cannabis Rescheduling

December 19, 2025

President Donald Trump signs executive order to reschedule cannabis

Cannabis Rescheduling is Here: Trump Signs Executive Order to Move Cannabis to Schedule III

December 19, 2025

CONNECT

Trump considers using executive order to reschedule cannabis

Republican Lawmakers Openly Defy Trump on Cannabis Rescheduling

by Ben Stevens

January 13, 2026

As the excitement around President Donald Trump's executive order to push forward with cannabis rescheduling has faded, the bill is...

SOMAÍ and Universidade Lusófona Publish Peer-Reviewed Study Validating Full-Spectrum Oil Consistency

by Business of Cannabis

January 13, 2026

SOMAÍ, a leading EU-GMP-certified vertically integrated Multi-Country Operator (MCO) specialising in cannabinoid-based medicines, together with Universidade Lusófona, has published their...